|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and ad- vanced Hodgkin lymphoma显示文摘 | Cerci J J Pracchia LF Linardi CC | 2010 | J Nucl Med2010，51，9： | 1 |
| 2 | ^sup 18^F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma显示文摘 | Cerci Juliano J Pracchia Luís F Linardi Camila C G Pitella Felipe A Delbeke Dominique Izaki Marisa Trindade Evelinda Junior José Soares Buccheri Valeria Meneghetti José C | 2010 | The Journal of Nuclear Medicine2010，，： | 1 |
| 3 | Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil显示文摘 | PereiraJ Bellesso M Pracchia LF | 2006 | Leuk Res2006，30，6： | 1 |
| 4 | Diagnosis and treatment of polycythemia vera: Brazilian experience from a single institution显示文摘 | Linardi Cda C Pracchia LF Buccheri V | 2008 | Sao Paulo Med J2008，126，1： | 1 |
| 5 | 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma显示文摘 | Cerci JJ Pracchia LF Linardi CC | 2010 | J Nucl Med2010，51，9： | 1 |
| 6 | Progamstic Factors in Adolescent and Adult Patients With Acute Lymphoblastic Leuke- mia With Two Protocols of Chemotherapy: A Cross-Sectional Study显示文摘 | Pinheiro JE Pracchia LF Beitler DMB | 2015 | Clin Lymphoma Myeloma Leuk2015，15，1： | 1 |
| 7 | Positron emission tomography with 2- fluoro-2-deoxy-F)-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil显示文摘 | Cerci JJ Pracchia LF Soares Junior J | 2009 | Clinics (Sao Paulo)2009，64，6： | 1 |
| 8 | 2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma显示文摘AIM:To assess the prognostic value and risk classification improvement of metabolic staging(MS)with Initial2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography(FDG-PET)in initial staging of Hodgkin’s Lymphoma(HL)patients to predict 5 years overall survival(5y-OS)and event free survival(EFS).METHODS:A total of 275 patients were included in this retrospective study,155 patients were staged with conventional anatomical staging(AS),and 120 also submitted to MS(FDG-PET).Prognostic analysis compared 5y-OS and 5y-EFS of patients staged with AS and MS.Risk-adjusted models incorporated clinical risk factors,computed tomography and FDG-PET staging.RESULTS:During the follow up of 267 evaluated patients,220(122 AS and 98 MS)achieved complete remission after first-line therapy(median follow-up:70±29 mo),treatment failure occurred in 79 patients and 34 died.The 5y-EFS for early vs advanced disease in AS patients was 79.3%and 66.7%,and 85.6%and53.6%in MS patients,respectively(P<0.01).The5y-OS for early and advanced disease with AS was91.3%and 81.5%,and 97.5%and 80.7%for patients staged with MS,respectively.Cox proportional hazards analysis demonstrated that FDG-PET added signifcant prognostic information and improved risk prediction(P=0.02).CONCLUSION:Initial staging FDG-PET could be used as an accurate and independent predictor of OS and EFS in HL,with impact in 5y-EFS and OS. | Juliano J Cerci Camila C G Linardi Luís F Pracchia José Soares Junior Evelinda Trindade Dominique Delbeke Rodrigo J Cerci Robert Carr José C Meneghetti Valeria Buccheri | 2013 | World Journal of Radiology2013，5，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员